Related references
Note: Only part of the references are listed.Nanoparticle Delivery Systems in Cancer Vaccines
Yogita Krishnamachari et al.
PHARMACEUTICAL RESEARCH (2011)
A New Era for Cancer Treatment: Gold-Nanoparticle-Mediated Thermal Therapies
Laura C. Kennedy et al.
SMALL (2011)
Codelivery of adjuvants at the primary immunization site is essential for evoking a robust immune response to neoglycoconjugates
Dodi Safari et al.
VACCINE (2011)
What do the next 100 years hold for pneumococcal vaccination?
Ger T. Rijkers et al.
EXPERT REVIEW OF VACCINES (2010)
Synthesis of Multivalent Tuberculosis and Leishmania-Associated Capping Carbohydrates Reveals Structure-Dependent Responses Allowing Immune Evasion
Eun-Ho Song et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Synthesis of a Single-Molecule L-Rhamnose-Containing Three-Component Vaccine and Evaluation of Antigenicity in the Presence of Anti-L-Rhamnose Antibodies
Sourav Sarkar et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Glyconanoparticles: multifunctional nanomaterials for biomedical applications
Isabel Garcia et al.
NANOMEDICINE (2010)
Carbohydrate vaccines: developing sweet solutions to sticky situations?
Rena D. Astronomo et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity
Elodie Boisselier et al.
CHEMICAL SOCIETY REVIEWS (2009)
Gold Manno-Glyconanoparticies: Multivalent Systems to Block HIV-1 gp120 Binding to the Lectin DC-SIGN
Olga Martinez-Avila et al.
CHEMISTRY-A EUROPEAN JOURNAL (2009)
Carbohydrates: A Frontier in Medicinal Chemistry
Pierre Stallforth et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Peptides conjugated to gold nanoparticles induce macrophage activation
Neus G. Bastus et al.
MOLECULAR IMMUNOLOGY (2009)
Rational design and immunogenicity of liposome-based diepitope constructs: Application to synthetic oligosaccharides mimicking the Shigella flexneri 2a O-antigen
Fatouma Said Hassane et al.
VACCINE (2009)
Identification of the smallest structure capable of evoking opsonophagocytic antibodies against Streptococcus pneumoniae type 14
Dodi Safari et al.
INFECTION AND IMMUNITY (2008)
Both Th1 and Th17 are immunopathogenic but differ in other key biological activities
Catherine A. Cox et al.
JOURNAL OF IMMUNOLOGY (2008)
Design opportunities for actively targeted nanoparticle vaccines
Tarek M. Fahmy et al.
NANOMEDICINE (2008)
Tiopronin monolayer-protected silver nanoparticles modulate IL-6 secretion mediated by Toll-like receptor ligands
Paula M. Castillo et al.
NANOMEDICINE (2008)
An oligosaccharide-based HIV-1 2G12 mimotope vaccine induces carbohydrate-specific antibodies that fail to neutralize HIV-1 virions
Joseph G. Joyce et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN
Sheng-Kai Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Interleukin-17A mediates acquired immunity to pneumococcal colonization
Ying-Jie Lu et al.
PLOS PATHOGENS (2008)
Characterization of nanoparticles for therapeutics
Jennifer B. Hall et al.
NANOMEDICINE (2007)
Robust immune responses elicited by a fully synthetic three-component vaccine
Sampat Ingale et al.
NATURE CHEMICAL BIOLOGY (2007)
Preparation of multifunctional glyconanoparticles as a platform for potential carbohydrate-based anticancer vaccines
Rafael Ojeda et al.
CARBOHYDRATE RESEARCH (2007)
Epidermal DNA vaccine for influenza is immunogenic in humans
Robert J. Drape et al.
VACCINE (2006)
Block synthesis of Streptococcus pneumoniae type 14 capsular polysaccharide structures
A Sundgren et al.
JOURNAL OF CARBOHYDRATE CHEMISTRY (2005)
Self-assembled monolayers of thiolates on metals as a form of nanotechnology
JC Love et al.
CHEMICAL REVIEWS (2005)
A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b
V Verez-Bencomo et al.
SCIENCE (2004)
Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study
R Veenhoven et al.
LANCET (2003)
Gold glyconanoparticles:: Synthetic polyvalent ligands mimicking glycocalyx-like surfaces as tools for glycobiological studies
AG Barrientos et al.
CHEMISTRY-A EUROPEAN JOURNAL (2003)
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine
CG Whitney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Immunogenicity in a mouse model of a conjugate vaccine made with a synthetic single repeating unit of type 14 pneumococcal polysaccharide coupled to CRM197
F Mawas et al.
INFECTION AND IMMUNITY (2002)
Activation of cell-mediated immunity following immunization with pneumococcal conjugate or polysaccharide vaccine
T Wuorimaa et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2001)
Induction of antigen-specific CD8+T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine
MJ Roy et al.
VACCINE (2000)